Elisabeth Picou

Fondateur chez BCI Pharma SAS

Commercial Services

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Dominique Surleraux	M	-	BCI Pharma SAS BCI Pharma SAS Miscellaneous Commercial ServicesCommercial Services BCI Pharma SAS engages in research and development in biotechnology. Its kinase platform is based on a new chemotype with phys-chem properties, able to explore a new chemical space for treating CNS, inflammation, cancer and metabolic diseases. The firm also offers medicinal chemistry, HTS platform and consultancy services. The company was founded by Elisabeth Picou and Dominique Surleraux in March 2013 and is headquartered in Grabels, France.	11 ans
Didier Malherbe	M	-	BCI Pharma SAS BCI Pharma SAS Miscellaneous Commercial ServicesCommercial Services BCI Pharma SAS engages in research and development in biotechnology. Its kinase platform is based on a new chemotype with phys-chem properties, able to explore a new chemical space for treating CNS, inflammation, cancer and metabolic diseases. The firm also offers medicinal chemistry, HTS platform and consultancy services. The company was founded by Elisabeth Picou and Dominique Surleraux in March 2013 and is headquartered in Grabels, France.	4 ans
Jean-Marc Legrand	M	-	BCI Pharma SAS BCI Pharma SAS Miscellaneous Commercial ServicesCommercial Services BCI Pharma SAS engages in research and development in biotechnology. Its kinase platform is based on a new chemotype with phys-chem properties, able to explore a new chemical space for treating CNS, inflammation, cancer and metabolic diseases. The firm also offers medicinal chemistry, HTS platform and consultancy services. The company was founded by Elisabeth Picou and Dominique Surleraux in March 2013 and is headquartered in Grabels, France.	7 ans
Frederic Schynts	M	-	BCI Pharma SAS BCI Pharma SAS Miscellaneous Commercial ServicesCommercial Services BCI Pharma SAS engages in research and development in biotechnology. Its kinase platform is based on a new chemotype with phys-chem properties, able to explore a new chemical space for treating CNS, inflammation, cancer and metabolic diseases. The firm also offers medicinal chemistry, HTS platform and consultancy services. The company was founded by Elisabeth Picou and Dominique Surleraux in March 2013 and is headquartered in Grabels, France.	5 ans
Cyril Dousson	M	-	BCI Pharma SAS BCI Pharma SAS Miscellaneous Commercial ServicesCommercial Services BCI Pharma SAS engages in research and development in biotechnology. Its kinase platform is based on a new chemotype with phys-chem properties, able to explore a new chemical space for treating CNS, inflammation, cancer and metabolic diseases. The firm also offers medicinal chemistry, HTS platform and consultancy services. The company was founded by Elisabeth Picou and Dominique Surleraux in March 2013 and is headquartered in Grabels, France.	3 ans